Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tonicard Gold Drop is a homeopathic formulation developed and marketed by SBL Private (SBL Homoeopathy), a prominent Indian manufacturer of homeopathic products. It is positioned as a cardiac tonic intended to improve the efficiency of the heart muscle and maintain heart health. The product is a combination of several homeopathic ingredients, including *Cactus grandiflorus*, *Crataegus oxyacantha*, *Convallaria majalis*, *Valeriana officinalis*, *Aurum muriaticum natronatum*, *Camphora*, *Ignatia amara*, and *Terminalia arjuna*. It is typically indicated for the relief of palpitations, anxiety, breathlessness, and as a supportive therapy in various heart conditions. As a homeopathic remedy, it is available over-the-counter and does not follow the traditional pharmaceutical clinical trial pipeline.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tonicard Gold Drop.